Board MeetingOutcome of Board Meeting
Board approves ₹2,941.19 crore corporate guarantee for subsidiary, ₹200 crore promoter infusion, and FY2025-26 Cost Audit Report
Financial actions
- Approved corporate guarantee for wholly-owned subsidiary up to ₹2,941.19 crore to secure credit facilities.
- Approved promoter contribution infusion up to ₹200 crore for project financing.
- Infusion may be via equity, loans, NCDs, OCDs, quasi-equity, or combinations per financing needs.
Audit and regulatory disclosures
- Approved Cost Audit Report for FY2025-26; authenticated by M/s R. R. Ahirwar & Associates.
- Annexures per SEBI circular enclosed as Annexure I and II.
Related party and contingent liability
- Corporate guarantee in favour of subsidiary; related party; arm's length basis.
- Terms and conditions yet to be finalised; further disclosures to follow with definitive documents.
- Contingent liability with no immediate impact unless subsidiary defaults.